Key result
Review details stepwise lifestyle and lipid-lowering therapies for moderate hypertriglyceridemia.
Why the study?
Guidelines for hypertriglyceridemia are variable without a global consensus on classification and triglyceride goals, yet moderate hypertriglyceridemia increases atherosclerotic cardiovascular disease risk.
Design
Review
Authors
Loading...
May guide moderate hypertriglyceridemia management; leaves open validation in dedicated RCTs.
Provides a practical, stepwise clinical approach to managing moderate hypertriglyceridemia to mitigate atherosclerotic cardiovascular disease risk.
Savitha Subramanian (2022) conducted a review in Moderate Hypertriglyceridemia. This review provides stepwise recommendations for diagnosing and managing moderate hypertriglyceridemia (200-500 mg/dL), emphasizing lifestyle adjustments and appropriate statin or nonstatin therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: